MIRA (Medicare Innovation Responsiveness Act of 2003) to overhaul US device industry coding & coverage process?
This article was originally published in Clinica
Medicare would be forced to stop using foreign pricing data and begin covering the routine healthcare costs of patients enrolled in clinical trials, under legislation introduced last week by Representatives Jim Ramstad and Anna Eshoo.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.